Cahaba Wealth Management Inc. Sells 1,526 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cahaba Wealth Management Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 52.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,358 shares of the healthcare conglomerate’s stock after selling 1,526 shares during the period. Cahaba Wealth Management Inc.’s holdings in UnitedHealth Group were worth $794,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC raised its position in shares of UnitedHealth Group by 58.1% during the 1st quarter. International Assets Investment Management LLC now owns 7,062 shares of the healthcare conglomerate’s stock valued at $3,458,000 after buying an additional 2,594 shares in the last quarter. Unique Wealth LLC lifted its stake in shares of UnitedHealth Group by 30.8% in the 1st quarter. Unique Wealth LLC now owns 2,869 shares of the healthcare conglomerate’s stock valued at $1,427,000 after purchasing an additional 676 shares during the last quarter. Salem Investment Counselors Inc. increased its position in shares of UnitedHealth Group by 7.8% during the 1st quarter. Salem Investment Counselors Inc. now owns 38,702 shares of the healthcare conglomerate’s stock valued at $19,146,000 after purchasing an additional 2,796 shares during the last quarter. Cooper Financial Group lifted its position in UnitedHealth Group by 8.0% in the first quarter. Cooper Financial Group now owns 2,239 shares of the healthcare conglomerate’s stock worth $1,108,000 after buying an additional 165 shares during the last quarter. Finally, Orser Capital Management LLC raised its stake in shares of UnitedHealth Group by 128.4% in the first quarter. Orser Capital Management LLC now owns 1,028 shares of the healthcare conglomerate’s stock valued at $509,000 after acquiring an additional 578 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $569.61 on Friday. The firm has a 50-day simple moving average of $584.42 and a two-hundred day simple moving average of $534.15. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The firm has a market cap of $524.26 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the firm posted $6.56 earnings per share. The business’s quarterly revenue was up 9.2% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analysts Set New Price Targets

Several equities analysts recently commented on UNH shares. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday. KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Wells Fargo & Company increased their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald upped their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Stephens lowered their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $615.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.